Stay Updated
Press Releases
New Report Reveals Big Pharma’s Influence On Patient Advocacy Groups
WASHINGTON, D.C. — The web of money and influence built by Big Pharma over decades extends deeply into organizations that represent patients or claim to represent patients, creating conflicts of interest and constraints on even the most respected groups when it comes to critical drug pricing reforms. Those are the findings of a new report issued […]
Press Releases
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Alzheimer’s Association’s recent statement reacting to Biogen’s price of $56,000 for Aduhelm, a new drug aimed at targeting the disease process of Alzheimer’s instead of just treating symptoms: “As patients who are […]
Press Releases
STATEMENT: Aducanumab FDA Approval And Biogen's Pricing Prove Urgent Need For Medicare Negotiation
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, in response to the Food and Drug Administration’s approval of aducanumab, a new drug aimed at targeting the disease process of Alzheimer’s disease instead of just treating symptoms. The drug maker Biogen has set a price […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) released a new video today debunking Big Pharma’s myth that any limits on its unilateral power to dictate prices on brand-name drugs will kill innovation and new drug development. The video summarizes P4AD’s report Big Pharma’s Big Lie: The Truth About Innovation and Drug Prices, which details […]
Press Releases
ICYMI: New York Times Opinion: Taxpayers Fund Research and Drug Companies Make a Fortune
WASHINGTON, D.C. — The New York Times today published an op-ed by David Mitchell, cancer patient and founder of Patients For Affordable Drugs, breaking down how the COVID-19 vaccine story makes it clearer than ever why Americans need our government to negotiate prices for all prescription drugs – including vaccines. Mitchell’s piece is in response to […]
Press Releases
Patients For Affordable Drugs Announces New Communications Director
WASHINGTON, D.C. — The bipartisan advocacy organization Patients For Affordable Drugs, and its sister organization Patients For Affordable Drugs Now, today named Audrey Baker as its communications director. Audrey will take leadership of overall communications, including media relations. Audrey has worked in advocacy communications for over five years, most recently at the communications firm M+R, […]
Press Releases
Big Pharma’s Big Lie: The Truth About Innovation and Drug Pricing
WASHINGTON, D.C. — A new report from Patients For Affordable Drugs takes on Big Pharma’s long-standing claim that any constraints on its pricing power will destroy innovation and access to valuable new medicines, and shows why it is clearly possible for Americans to enjoy both innovation and lower prices. “I have an incurable blood cancer; […]
Press Releases
Patients For Affordable Drugs Names Executive Director
WASHINGTON, D.C. — The bipartisan advocacy organization Patients For Affordable Drugs, and its sister organization Patients For Affordable Drugs Now, welcomes Sheila McLean as its executive director to lead the charge in the fight to lower drug prices. Over more than three decades, McLean has driven change in public health, health care, social impact, and […]